(+)-pinoresinol-4-O-β-D-glucopyraside for COVID-19

 (+)-pinoresinol-4-O-β-D-glucopyraside has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed (+)-pinoresinol-4-O-β-D-glucopyraside in detail.
Su et al., Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients, Acta Pharmacologica Sinica, doi:10.1038/s41401-020-0483-6